There are a few ongoing large randomized controlled trials (RCT's) on continuous glucose monitoring (CGM) in women with gestational diabetes (GDM) powered for pregnancy outcomes. However, none of these studies included women diagnosed with early GDM. The CORDELIA trial is a Belgian-Australian open-label multi-centric RCT with 16 centers in women with GDM (including both early and late GDM). Women will be randomized 1/1 to either treatment with CGM (intervention group, Freestyle Libre 3 +) or continue with self-monitoring of blood glucose (SMBG) with glucometer in line with normal routine (control arm). The study ends at the postpartum oral glucose tolerance test (OGTT 6-24 weeks postpartum) to screen for glucose intolerance.
At diagnosis of GDM, women will receive education on the management of GDM with lifestyle and need to monitor glucose with SMBG. Within one week of GDM diagnosis, all participants will be asked to use a blinded CGM (Freestyle Libre Pro IQ,) during a run-phase. Women randomized to the control arm, will be asked to intermittently wear a blinded CGM sensor (Freestyle Libre Pro IQ) during 14 days at least two time points in pregnancy (at 31.0-33.6 weeks and between 36.0-38.6 weeks). For women diagnosed with early GDM (\<20 weeks), blinded CGM will be needed 3 times in pregnancy with a first time at 20.0-23.9 weeks. Women randomized to the intervention arm will be recommended tu use the rt-CGM (Freestyle Libre 3) till the delivery. In line with normal routine, a 75g OGTT will be performed between 6-24 weeks postpartum to screen for glucose intolerance. Participants will be asked to also wear a blinded CGM (Freestyle Libre Pro IQ) at this last study visit.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
386
CGM
SMBG
Campbelltown Hospital
Sydney, CAMPBELLTOWN NSW, Australia
RECRUITINGRoyal Prince Alfred Hospital
Sydney, Camperdown NSW, Australia
RECRUITINGOLV Aalst-Asse
Aalst, Oost-Vlaanderen, Belgium
RECRUITINGUZA
Antwerp, Belgium
RECRUITINGZNA Antwerpen
Antwerp, Belgium
RECRUITINGImelda Bonheiden
Bonheiden, Belgium
RECRUITINGAZ St Jan Brugge
Bruges, Belgium
RECRUITINGErasme
Brussels, Belgium
RECRUITINGUZ Gent
Ghent, Belgium
RECRUITINGAZ St Lucas Gent
Ghent, Belgium
RECRUITING...and 6 more locations
a composite of pregnancy outcomes
Hence, the primary outcome is a binary variable, taking the value 1 if at least one of the adverse pregnancy outcomes occurs, or zero otherwise:preterm delivery \<37 weeks, large-for-gestational age infant, neonatal hypoglycaemia, (requiring intravenous dextrose), NICU admission (\>24h), respiratory distress (at least 4 hours of respiratory support with supplemental oxygen, CPAP, or intermittent positive-pressure ventilation during the first 24 hours after delivery), stillbirth or neonatal death, phototherapy for jaundice, birth trauma and shoulder dystocia
Time frame: at delivery
time in glucose range overnight between 70-95mg/dl
time in range from 00 till 6am between 70-95mg/dl
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks
time in glucose range during the day between 70-95mg/dl
time in range from 06 am til 00 between 70-95mg/dl
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks
time in glucose range overnight between 63-140mg/dl
time in range from 00 till 6am between 63-140mg/dl
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks of gestation
time in glucoserange during the day between 63-140mg/dl
time in range from 06 am til 00 between 63-140mg/dl
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks
time in glucose range during the day between 54-95mg/dl
time in range from 06 am til 00 between 54-95mg/dl
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks
time in glucose range overnight between 54-95mg/dl
time in range from 00 till 6am between 54-95mg/dl
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks
time in glucose range overnight between 63-120mg/dl
time in range from 00 till 6am between 63-120mg/dl
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks
time in glucose range during the day between 63-120mg/dl
time in range from 06 am til 00 between 63-120mg/dl
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks
hypoglycemia <54mg/dl
time below 54mg/dl
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks
hypoglycemia <50mg/dl
time below 50mg/dl
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks
hypoglycemia <63mg/dl
time below 63mg/dl
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks
hypoglycemia <70mg/dl
time below 70mg/dl
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks
standard deviation
glycemic variability measured by standard deviation (SD)
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks
Coefficient of Variance
glycemic variability measured by coefficient of variance (CV)
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks
mean amplitude of glycemic excursions
glycemic variability measured by mean amplitude of glycemic excursions (MAGE)
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks
glucose time overnight >100mg/dl
time in range from 00 till 6am \>100mg/dl
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks
glucose postprandial time >120mg/dl
postprandial time \>120mg/dl 2hours after the meal
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks
glucose postprandial time >140mg/dl
postprandial time \>140mg/dl 1hour after the meal
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks
glucose time >180mg/dl
time \>180mg/dl
Time frame: during 2 weeks between 20.0-23.6 weeks, 31.0-33.6 weeks, and 36.0-38.6 weeks
mean HbA1c
glycated Hb
Time frame: between 20.0-23.6 weeks, 31.0-33.6 weeks, 36.0-38.6 weeks and 6-24 weeks postpartum
Glucose management indicator
Glucose management indicator, GMI
Time frame: between 20.0-23.6 weeks, 31.0-33.6 weeks, 36.0-38.6 weeks and 6-24 weeks postpartum
timing of start insulin treatment
gestational age at start insulin treatment
Time frame: from GDM diagnosis till delivery
mean insulin dose
dose of short and/or long)actinbg insulin
Time frame: from GDM diagnosis till delivery
mean gestational weight gain
weight gain in pregnancy
Time frame: at delivery
rate of postpartum hemorrhage
hemorrhage with delivery
Time frame: at delivery
rate of macrosomia
birth weight \>4Kg
Time frame: at delivery
rate of baby >4.5Kg
birth weight \>4.5Kg
Time frame: at delivery
rate of Small-for-gestational age infant
birth weight \<10Th percentile
Time frame: at delivery
rate of cesarean section
total (planned and emergency) number of cesarean sections
Time frame: at delivery
rate of instrumental delivery
delivery with forceps or vacuum
Time frame: at delivery
rate of perineal inury
3dr or 4th degree perineal laceration
Time frame: at delivery
rate of labor inductions
induction of labor
Time frame: at delivery
rate of preeclamspia
\[≥20 weeks of gestation: new onset of hypertension and proteinuria or the new onset of hypertension and significant end-organ dysfunction with or without proteinuria (dipstick ≥ 2+, ≥0.3 g protein/24 hours or ≥30 mg/dL protein in spot urine or spot urine protein / creatinine ratio ≥30 mg protein/mmol creatinine
Time frame: at delivery
rate of gestational hypertension
≥20 weeks of gestation: blood pressure ≥140/90mmHg
Time frame: at delivery
rate of fetal malformation
congenital malformation
Time frame: at delivery
rate of miscarriage
fetal loss \<20 weeks gestation
Time frame: at delivery
rate of polycythemia
increased hematocrite accoridng to local practice
Time frame: at delivery
rate of neonatal hypoglycemia
bypoglycemia at birth \<40mg/dl
Time frame: at delivery
Treatment satisfaction
diabetes treatment satisfaction questionnaire score, the higher the score the more satisfied, max. score of 48
Time frame: between 31.0-33.6 weeks, 36.0-38.6 weeks and 6-24 weeks postpartum
Quality of life based on Short Form (SF-36) score
Short Form (SF-36) score, the higher the score the higher the Quality of life with a max score of 100
Time frame: baseline, between 36.0-38.6 weeks and 6-24 weeks postpartum
dietary intake
Frequyency Food Questionnaire
Time frame: baseline, between 36.0-38.6 weeks and 6-24 weeks postpartum
Physical activity
International Physical Activity questionnaire score
Time frame: baseline, between 36.0-38.6 weeks and 6-24 weeks postpartum
fear for hypoglycaemia
the Hypoglycaemia Fear Survey II
Time frame: between 36.0-38.6 weeks
fear for hyperglycaemia
self-designed questionnaire on fear for hyperglycaemia
Time frame: between 36.0-38.6 weeks
symptoms of depression
the 20-item Center for Epidemiologic Studies-Depression (CES-D) , questionnaire, max. score 60 (the higher the more symptoms of depression)
Time frame: baseline, between 36.0-38.6 weeks and 6-24 weeks postpartum
symptoms of anxiety
validated six-item short-form STAI questionnaire on anxiety, max. score of 24 (the higher the more anxiety)
Time frame: baseline, between 36.0-38.6 weeks and 6-24 weeks postpartum
user-friendliness of CGM
self-designed questionnaire on the user-friendliness of continuous glucose monitoring (CGM)
Time frame: between 36.0-38.6 weeks
user-friendliness of CGM compared to oral glucose tolerance test (OGTT)
self-designed questionnaire on the user-friendliness of continuous glucose monitoring (CGM) compared to OGTT
Time frame: between 6-24 weeks postpartum
duration of breastfeeding
breastfeeding duration (exclusive or half formula) duration in months
Time frame: postpartum between 6-24 weeks
rate of hypercholesterolemia
lipid profile with LDL-cholesterol and Triglycerides
Time frame: postpartum between 6-24 weeks
night glucose time in range between 70-180mg/dl
glucose time in range between 70-180mg/dl from 00 til 6am
Time frame: postpartum between 6-24 weeks
day glucose time in range between 70-180mg/dl
glucose time in range between 70-180mg/dl from 6am till 00
Time frame: postpartum between 6-24 weeks
day glucose time in range <70mg/dl
glucose time below 70-mg/dl from 6am till 00
Time frame: postpartum between 6-24 weeks
night glucose time in range <70mg/dl
glucose time below 70-mg/dl from 00 till 6am
Time frame: postpartum between 6-24 weeks
night glucose time in range >180mg/dl
glucose time above 180mg/dl from 00 till 6am
Time frame: postpartum between 6-24 weeks
day glucose time in range >180mg/dl
glucose time above 180mg/dl from 6am till 00
Time frame: postpartum between 6-24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.